Comparison between Avience Biomedicals IPO and Smarten Power Systems IPO.
Avience Biomedicals IPO is a SME Fixed Price IPO proposed to list at NSE SME while Smarten Power Systems IPO is a SME Fixed Price proposed to list at NSE SME.
| Avience Biomedicals IPO | Smarten Power Systems IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Fintellectual Corporate Advisors Pvt.Ltd. | Arihant Capital Markets Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Maashitla Securities Pvt.Ltd. |
| Market Maker | Asnani Stock Broker Pvt.Ltd. | Arihant Capital Markets Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Avience Biomedicals IPO is up to ₹28.53 Cr whereas the issue size of the Smarten Power Systems IPO is up to ₹47.50 Cr. The final issue price of Avience Biomedicals IPO is ₹208.00 per share and of Smarten Power Systems IPO is ₹100.00 per share.
| Avience Biomedicals IPO | Smarten Power Systems IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹196.00 per share | |
| Issue Price (Upper) | ₹208.00 per share | |
| Issue Price (Final) | ₹208.00 per share | ₹100.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 600 shares | 1200 shares |
| Fresh Issue Size | 13,71,600 shares | 37,50,000 shares |
| Fresh Issue Size (Amount) | up to ₹28.53 Cr | up to ₹37.50 Cr |
| OFS Issue Size | 0 shares | 9,99,600 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹10.00 Cr |
| Issue Size Total | 13,71,600 shares | 47,49,600 shares |
| Issue Size Total (Amount) | up to ₹28.53 Cr | up to ₹47.50 Cr |
Avience Biomedicals IPO opens on Jun 18, 2026, while Smarten Power Systems IPO opens on Jul 07, 2025. The closing date of Avience Biomedicals IPO and Smarten Power Systems IPO is Jun 22, 2026, and Jul 09, 2025, respectively.
| Avience Biomedicals IPO | Smarten Power Systems IPO | |
|---|---|---|
| Anchor Bid Date | Jun 17, 2026 | |
| Issue Open | Jun 18, 2026 | Jul 07, 2025 |
| Issue Close | Jun 22, 2026 | Jul 09, 2025 |
| Basis Of Allotment (Tentative) | Jun 23, 2026 | Jul 10, 2025 |
| Initiation of Refunds (Tentative) | Jun 24, 2026 | Jul 11, 2025 |
| Credit of Share (Tentative) | Jun 24, 2026 | Jul 11, 2025 |
| Listing date (Tentative) | Jun 25, 2026 | Jul 14, 2025 |
| Anchor Lockin End date 1 | Jul 23, 2026 | |
| Anchor Lockin End date 2 | Sep 21, 2026 |
Avience Biomedicals IPO P/E ratio is 11.59, as compared to Smarten Power Systems IPO P/E ratio of 11.75.
| Avience Biomedicals IPO | Smarten Power Systems IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 87.89 | 91.67 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 64.59 | 67.1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 11.59 | 11.75 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹114.09 Cr. | ₹190.01 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 50.14 | 39.72 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 24.84 | 32.58 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.97 | 0.43 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹17.94 | ₹8.51 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 49.89 | 33.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Avience Biomedicals IPO Retail Individual Investors (RII) are offered 4,81,200 shares while in Smarten Power Systems IPO retail investors are offered 4,81,200 shares. Qualified Institutional Buyers (QIB) are offered 2,73,600 shares in Avience Biomedicals IPO and 0 shares in Smarten Power Systems IPO.
| Avience Biomedicals IPO | Smarten Power Systems IPO | |
|---|---|---|
| Anchor Investor Reservation | 4,09,800 shares | 0 shares |
| Market Maker Reservation | 82,200 shares | 2,50,800 shares |
| QIB | 2,73,600 shares | 0 shares |
| NII | 2,07,000 shares | 23,74,800 shares |
| RII | 4,81,200 shares | 23,74,800 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 13,71,600 shares | 47,49,600 shares |
Avience Biomedicals IPO subscribed 270.19x in total, whereas Smarten Power Systems IPO subscribed 5.49x.
| Avience Biomedicals IPO | Smarten Power Systems IPO | |
|---|---|---|
| QIB (times) | 196.77x | |
| NII (times) | 597.23x | 6.31x |
| Big NII (times) | 670.18x | |
| Small NII (times) | 451.35x | |
| RII (times) | 401.36x | 4.66x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 270.19x | 5.49x |
